CN115813844A - Cream oil bead essence composition and preparation method thereof - Google Patents
Cream oil bead essence composition and preparation method thereof Download PDFInfo
- Publication number
- CN115813844A CN115813844A CN202210202527.7A CN202210202527A CN115813844A CN 115813844 A CN115813844 A CN 115813844A CN 202210202527 A CN202210202527 A CN 202210202527A CN 115813844 A CN115813844 A CN 115813844A
- Authority
- CN
- China
- Prior art keywords
- phase
- oil
- extract
- cream
- dextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 239000011324 bead Substances 0.000 title claims abstract description 29
- 239000006071 cream Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 239000003921 oil Substances 0.000 claims abstract description 68
- 235000019198 oils Nutrition 0.000 claims abstract description 61
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 42
- 239000004375 Dextrin Substances 0.000 claims abstract description 35
- 229920001353 Dextrin Polymers 0.000 claims abstract description 35
- 235000019425 dextrin Nutrition 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- -1 fatty acid ester Chemical class 0.000 claims abstract description 18
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 17
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000008367 deionised water Substances 0.000 claims abstract description 16
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 16
- 239000003906 humectant Substances 0.000 claims abstract description 16
- 239000000419 plant extract Substances 0.000 claims abstract description 12
- 239000002562 thickening agent Substances 0.000 claims abstract description 12
- 229920000223 polyglycerol Polymers 0.000 claims abstract description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 9
- 150000002148 esters Chemical class 0.000 claims abstract description 9
- 239000000194 fatty acid Substances 0.000 claims abstract description 9
- 229930195729 fatty acid Natural products 0.000 claims abstract description 9
- 239000003755 preservative agent Substances 0.000 claims abstract description 9
- 230000002335 preservative effect Effects 0.000 claims abstract description 9
- 239000008158 vegetable oil Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 50
- 241000168517 Haematococcus lacustris Species 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 21
- 244000022198 Mirabilis jalapa Species 0.000 claims description 10
- 235000009053 Mirabilis jalapa Nutrition 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 229940105132 myristate Drugs 0.000 claims description 9
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 9
- 235000011449 Rosa Nutrition 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 240000001548 Camellia japonica Species 0.000 claims description 3
- 229940055034 hibiscus syriacus bark extract Drugs 0.000 claims description 3
- ZONJATNKKGGVSU-UHFFFAOYSA-M 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC([O-])=O ZONJATNKKGGVSU-UHFFFAOYSA-M 0.000 claims description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 2
- 241000157280 Aesculus hippocastanum Species 0.000 claims description 2
- 235000006467 Camellia japonica Nutrition 0.000 claims description 2
- 235000004283 Vitis amurensis Nutrition 0.000 claims description 2
- 240000002503 Vitis amurensis Species 0.000 claims description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims description 2
- 235000010181 horse chestnut Nutrition 0.000 claims description 2
- 229940070765 laurate Drugs 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 239000001301 oxygen Substances 0.000 abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 36
- 239000003925 fat Substances 0.000 description 26
- 235000019197 fats Nutrition 0.000 description 23
- 238000012360 testing method Methods 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 10
- 235000003222 Helianthus annuus Nutrition 0.000 description 10
- 235000004433 Simmondsia californica Nutrition 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 241000736199 Paeonia Species 0.000 description 9
- 235000006484 Paeonia officinalis Nutrition 0.000 description 9
- 238000005562 fading Methods 0.000 description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 8
- 244000130592 Hibiscus syriacus Species 0.000 description 8
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 8
- 241000727169 Prinsepia utilis Species 0.000 description 7
- 229920006037 cross link polymer Polymers 0.000 description 7
- 239000004519 grease Substances 0.000 description 7
- 229940042585 tocopherol acetate Drugs 0.000 description 7
- 235000019871 vegetable fat Nutrition 0.000 description 7
- 239000004475 Arginine Substances 0.000 description 6
- 241000526900 Camellia oleifera Species 0.000 description 6
- 241000208818 Helianthus Species 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 6
- 229940043234 carbomer-940 Drugs 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 241000219470 Mirabilis Species 0.000 description 5
- 241000221095 Simmondsia Species 0.000 description 5
- 244000044822 Simmondsia californica Species 0.000 description 5
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 5
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- 241000983387 Adenium obesum Species 0.000 description 4
- 235000005976 Citrus sinensis Nutrition 0.000 description 4
- 240000002319 Citrus sinensis Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 244000020551 Helianthus annuus Species 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 241001135917 Vitellaria paradoxa Species 0.000 description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 229940057910 shea butter Drugs 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 235000005206 Hibiscus Nutrition 0.000 description 3
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 3
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 244000261559 Smilax china Species 0.000 description 3
- 235000000485 Smilax china Nutrition 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 235000021384 green leafy vegetables Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- 241001531051 Potentilla chinensis Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000983381 Adenium Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241001530056 Athelia rolfsii Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- NEZONWMXZKDMKF-UHFFFAOYSA-N C.I. Natural Red 20 Chemical compound C1=CC(O)=C2C(=O)C(C(O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 241001504226 Hoodia Species 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 240000004035 Lithospermum officinale Species 0.000 description 1
- 235000011030 Lithospermum officinale Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000694540 Pluvialis Species 0.000 description 1
- 241000210050 Potentilla alba Species 0.000 description 1
- 244000050053 Rosa multiflora Species 0.000 description 1
- 235000000656 Rosa multiflora Nutrition 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 235000017277 hoodia Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000010487 meadowfoam seed oil Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
Abstract
The invention provides a condensed fat oil bead essence composition and a preparation method thereof, wherein the preparation raw materials are divided into phase A: dextrin fatty acid ester, polyglycerol ester, vegetable oil, antioxidant I and skin conditioner I; phase B: a nourishing component, an antibacterial component, a plant extract, a skin conditioner II; and C phase: thickening agent, antioxidant II, humectant, preservative, pH regulator and deionized water. The gel fat oil bead essence prepared by the invention has moderate hardness, is clear and transparent, is easy to spread on the surface of the skin and has good compatibility with the skin. The cream oil bead essence prepared by the method disclosed by the invention is good in stability, and can effectively separate active ingredients in an oil phase from free oxygen and other ingredients in a water phase, so that the efficacy of the oily active ingredients is protected, and the skin care effect is improved.
Description
Technical Field
The invention relates to the technical field of A61K8/92, and particularly relates to a cream oil bead essence composition and a preparation method thereof.
Background
The haematococcus pluvialis extract is rich in natural astaxanthin, and is commonly added to the field of skin care products to prepare antioxidant and anti-aging essence, emulsion, cream, mask and the like, but the haematococcus pluvialis extract is low in stability, easy to oxidize and easy to photolyze due to the high content of the natural astaxanthin. The oil extracted from natural plants is rich in various saturated fatty acids and unsaturated fatty acids, also contains a large amount of amino acids required by human bodies, rich nutrient components such as isoflavone compounds, vitamin E, trace elements and the like, maintains the moisture of the skin, softens the skin, and plays a role in nourishing and protecting.
Chinese patent CN111096929A discloses an essence liquid, wherein haematococcus pluvialis and various aquatic animal fats are used as oil phases, the essence liquid with the oil phases capable of being coagulated into oil droplets is prepared, but the oil droplets prepared by the essence liquid are unstable, are easy to disperse after shaking and can be coagulated after standing, and due to the design, the haematococcus pluvialis is enabled to continuously contact with oxidizing substances in the water phase, so that the stability of the haematococcus pluvialis cannot be well improved.
Based on the above, the application provides the condensed fat oil bead essence composition and the preparation method thereof, the oil phase substance is prepared into the condensed fat oil beads, the condensed fat oil beads have good stability in a water system, the condensed fat oil beads are not easy to shake and disperse, and the stability of functional components such as haematococcus pluvialis and the like is improved.
Disclosure of Invention
The invention provides a curdled oil bead essence composition in a first aspect, which is prepared from the following raw materials:
phase A: dextrin fatty acid ester, polyglycerol ester, vegetable oil, antioxidant I and skin conditioner I;
phase B: a nourishing component, an antibacterial component, a plant extract, a skin conditioner II;
and C phase: thickening agent, antioxidant II, humectant, preservative, pH regulator and deionized water;
the sum of the mass percentages of the phase A, the phase B and the phase C is 100 percent.
In a preferred embodiment, the dextrin fatty acid ester in the a phase is selected from at least one of dextrin palmitate, dextrin myristate, dextrin stearate, dextrin laurate, dextrin isostearate, and dextrin isopalmitate.
In a preferred embodiment, the dextrin fatty acid ester in the a phase is dextrin palmitate, dextrin myristate. Preferably, the mass ratio of dextrin palmitate to dextrin myristate is 2: (1-3). More preferably, the mass ratio of dextrin palmitate to dextrin myristate is 2.
In a preferred embodiment, the vegetable oil and fat in phase a is at least one selected from the group consisting of seabuckthorn oil, gromwell oil, jojoba oil, sweet orange grease, shea butter, grape seed oil, and sweet almond oil.
In a preferred embodiment, the vegetable oil and fat in phase a is sweet orange grease or shea butter.
In a preferred embodiment, the mass ratio of the sweet orange butter to the shea butter is 1.
In a preferred embodiment, the antioxidant I is tert-butylhydroquinone.
In a preferred embodiment, the skin conditioning agent I is selected from at least one of caprylic/capric triglyceride, HDI/trimethylol hexyl lactone crosspolymer, hydrogenated C6-C14 alkene polymer, hydrogenated C6-C20 polyolefin, caprylic triglyceride.
In a preferred embodiment, the skin conditioner I is an HDI/trimethylol hexyl lactone crosspolymer.
In a preferred embodiment, the raw materials in the phase A comprise, by mass, 0.1-20% of dextrin fatty acid ester, 0.1-20% of polyglycerol ester, 0.1-20% of vegetable fat, 0.01-1% of antioxidant I and 0.1-10% of skin conditioner I.
More preferably, the raw materials in the phase A comprise, by mass, 5% of dextrin fatty acid ester, 1% of polyglycerol ester, 4% of vegetable oil, 0.05% of antioxidant I and 0.8% of skin conditioner I.
In a preferred embodiment, the plant extract in phase B is at least one selected from the group consisting of haematococcus pluvialis extract, mirabilis jalapa extract, hibiscus bark extract, rosa multiflora leaf cell extract, vitis amurensis extract, camellia japonica extract, and aesculus hippocastanum seed extract.
More preferably, the plant extract is haematococcus pluvialis extract, mirabilis jalapa extract, hibiscus bark extract and rosa deserticola leaf cell extract.
In a preferred embodiment, the B phase further comprises a vitamin derivative. More preferably, the vitamin derivative is selected from fat-soluble vitamin derivatives, and more preferably, the fat-soluble vitamin derivatives are selected from at least one of tocopherol acetate, retinoic acid, ascorbyl glucoside and ascorbyl palmitate. More preferably, the vitamin derivative is tocopherol acetate.
In a preferred embodiment, the mass ratio of the nourishing component, the antibacterial component and the skin conditioner II in the phase B is (1-3): (1-3): 1.
in a preferred embodiment, the mass ratio of the nourishing component, the antibacterial component and the skin conditioner II in the phase B is 1.5.
In a preferred embodiment, the weight ratio of the plant extract in the B phase is 35-40wt%.
In a preferred embodiment, the antimicrobial component is a plant antimicrobial agent, preferably sunflower seed oil and peony seed oil.
In a preferred embodiment, the nourishing component is a plant essential oil, preferably meadowfoam seed oil, jojoba seed oil.
In a preferred embodiment, the skin conditioner II is prinsepia utilis royle oil and camellia seed oil.
In a preferred embodiment, the mass ratio of the phase a to the phase B is (1-6): (1-3).
More preferably, the mass ratio of the A phase to the B phase is (2-6): (1-3).
More preferably, the mass ratio of the phase A to the phase B is (2-2.5): (1-1.5).
The applicant found in the experimental process that, in the present application, when the mass ratio of the phase a and the phase B is (2-2.5): (1-1.5), the hardness, transparency, moldability and skin-friendly ability of the obtained coagulated fat oil beads are improved. The applicant speculates that the possible reasons are that the solid fat formed in the phase A and the fat components except the plant extracts in the phase B are regulated at a proper proportion, so that the crystal sequence in the oil globule is changed, the transparency of the oil globule is improved, and the skin-friendly property of the oil globule is also improved. When the phase A is excessively added, the prepared oil droplets are too hard, the transparency is reduced, and when the phase B is excessively added, the forming degree of the oil droplets is reduced, and solid oil droplets with stable appearance cannot be formed. Meanwhile, the applicant also finds that when the mass ratio of the plant extract in the B phase is 35-40wt%, the formed condensed grease oil bead is high, and the active ingredients in the condensed grease oil bead are separated from free oxygen and other ingredients in the water phase by the protective layer formed by the oil phase, so that the situation that the original activity and properties of the active ingredients are lost due to oxidation is reduced, and the efficacy of the active ingredients is maintained.
In a preferred embodiment, the raw materials in the B phase comprise, by mass, 0.1-20% of a nourishing component, 0.1-20% of an antibacterial component, 0.01-20% of a plant extract, 0.1-10% of a skin conditioner II and 0.01-0.5% of a vitamin derivative.
In a preferred embodiment, the raw materials in the phase B comprise, by mass, 0.1-5% of peony (Paeonia SUFFRUTICOSA) seed oil, 0.1-10% of sunflower (Helianthus ANNUUS) seed oil, 0.1-5% of Camellia oleifera seed oil, 0.1-5% of Prinsepia utilis oil, 0.1-10% of Hoodia (Simdsia CHINENSIS) seed oil, 0.1-10% of Potentilla CHINENSIS seed oil, 0.01-5% of Haematococcus PLUVIALIS (Haematococcus PLUVIALIS) extract, 0.01-2% of Mirabilis JALAPA (Mirabilis japa) extract, 0.01-2% of Hibiscus SYRIACUS (Hibiscus SYRIACUS) bark extract, 0.01-2% of Rosa desert (Adenium OBESUM) leaf cell extract, and 0.01-0.5% of tocopherol acetate.
More preferably, the raw materials in the phase B comprise, by mass, 0.5% of peony (peony SUFFRUTICOSA) seed oil, 1% of sunflower (helioanthus ANNUUS) seed oil, 0.5% of camellia oleifera seed oil, 0.5% of prinsepia utilis oil, 1% of jojoba (SIMMONDSIA CHINENSIS) seed oil, 0.5% of chinaroot greens seed oil, 1% of HAEMATOCOCCUS PLUVIALIS (hamtococcus PLUVIALIS) extract, 0.5% of MIRABILIS JALAPA (MIRABILIS JALAPA) extract, 0.5% of HIBISCUS SYRIACUS bark extract, 0.5% of rosa deserticola (adonium) leaf cell extract, and 0.05% of tocopherol acetate.
In a preferred embodiment, the raw materials in the phase C comprise, by mass, 0.02-1% of a thickening agent, 0.01-5% of an antioxidant II, 1-15% of a humectant, 0.01-0.5% of a preservative, 0.01-2% of a pH regulator, and deionized water to make up the balance.
More preferably, the thickening agent is at least one selected from acrylic acid C10-30 alkanol acrylate cross-linked polymer, carbomer, xanthan gum, hyaluronic acid, cellulose ethers, sclerotium rolfsii and sodium alginate. More preferably, the thickener is carbomer 940.
In a preferred embodiment, the humectant is selected from at least one of methyl propylene glycol, glycerin, propylene glycol, butylene glycol, hexylene glycol, sorbitol, and pentylene glycol. More preferably, the humectant is methyl propylene glycol and glycerol, and the mass ratio of the methyl propylene glycol to the glycerol is 5.
In a preferred embodiment, the pH adjusting agent is selected from at least one of arginine, triethanolamine, citric acid, succinic acid, sodium citrate; the pH regulator is arginine.
In the present application, the kind of the antioxidant II is not particularly limited, and includes, but is not limited to, one of p-hydroxyacetophenone, gallic acid, di-tert-butyl-p-cresol, and butylated hydroxyanisole.
In the present application, the kind of the preservative is not particularly limited, and includes, but is not limited to, one of caprylhydroxamic acid, methylparaben, propylparaben, phenoxyethanol, and paraben.
In a preferred embodiment, the raw materials in the phase C comprise, by mass, 0.1% of a thickener, 0.15% of an antioxidant II, 7% of a humectant, 0.05% of a preservative, 0.1% of a pH regulator, and deionized water to make up the balance.
The second aspect of the invention provides a preparation method of a condensed fat oil bead essence composition, which comprises the following steps:
(1) Adding the phase A component into a stirring container, heating to 70-99 ℃, stirring and preserving heat until the phase A component is completely dissolved;
(2) Cooling to 50-90 ℃, adding the phase B component, mixing and stirring uniformly, and keeping the temperature at 50-90 ℃ to obtain a material I;
(3) Dispersing the thickener in the phase C uniformly by using 20-70% of humectant, adding 20-50% of deionized water, mixing and heating to 75-85 ℃, stirring and preserving heat until the thickener is completely dispersed uniformly, and then cooling to 50-90 ℃ to obtain a material II;
(4) Adding the material I into the material II under the stirring condition until the material I is uniformly dispersed to obtain a material III;
(5) Uniformly mixing and dissolving 10-30% of deionized water and a pH regulator, adding the material III, and uniformly stirring to obtain a material IV;
(6) Heating and dissolving the antioxidant II, the preservative, the rest of the humectant and the rest of the deionized water, cooling to below 45 ℃, adding the material IV, and uniformly stirring.
Compared with the prior art, the invention has the following beneficial effects:
1. according to the gel fat oil bead essence composition prepared by the invention, the gel fat oil bead has moderate hardness through a proper proportion between the phase A and the phase B, the transparency of the gel fat oil bead is improved, the gel fat oil bead essence is easy to spread on the surface of the skin, and the gel fat oil bead essence composition has good compatibility with the skin.
2. According to the gel fat oil bead essence composition prepared by the invention, the stability of the gel fat oil beads is further improved under the synergistic effect of the plant fat in the phase A and substances such as the nourishing component and the antibacterial component in the phase B, and the active ingredients in the oil phase are separated from the free oxygen and other ingredients in the water phase through the structure of the oil bead essence, so that the efficacy of the oily active ingredients is further protected, the oily ingredients and the active ingredients of the plant extract are coordinated, and the skin care effect is improved.
3. The condensed fat oil bead essence composition prepared by the invention selects specific and various vegetable fat, nourishing components and other substances, wherein the substances are rich in various saturated fatty acids and unsaturated fatty acids, amino acids required by a human body, abundant isoflavone compounds, vitamin E, trace elements and other nutrient components, and can maintain skin moisture, soften skin and nourish and protect the skin.
Drawings
Fig. 1 is a graph showing the change in water content of the stratum corneum of the skin after use of the cream and oil essence composition prepared in example 1 of the present application.
Fig. 2 is a graph showing the change in the level of hemoglobin in skin after use of the cream essence composition prepared in example 1 of the present application.
Fig. 3 is a graph showing changes in skin gloss after use of the cream essence composition prepared in example 1 of the present application.
Detailed Description
Example 1
The first aspect of this embodiment provides a cream oil bead essence composition, which is prepared from the following raw materials by mass:
phase A: 2% of dextrin palmitate, 3% of dextrin myristate, 1% of polyglycerol ester, 4% of vegetable fat, 0.05% of tert-butylhydroquinone and 0.8% of HDI/trihydroxymethyl hexyl lactone cross-linked polymer;
phase B: 0.5% of peony (peony SUFFRUTICOSA) seed oil, 1% of sunflower (helioanthus ANNUUS) seed oil, 0.5% of camellia oleifera seed oil, 0.5% of prinsepia utilis royle oil, 1% of SIMMONDSIA CHINENSIS seed oil, 0.5% of chinaroot greens seed oil, 1% of HAEMATOCOCCUS PLUVIALIS (HAEMATOCOCCUS PLUVIALIS) extract, 0.5% of MIRABILIS japa (MIRABILIS lapa) extract, 0.5% of HIBISCUS SYRIACUS bark extract, 0.5% of rosa deserticola (ADENIUM OBESUM) leaf cell extract, and 0.05% of tocopherol acetate;
and C phase: carbomer 940 0.1%, p-hydroxyacetophenone 0.15%, humectant 7%, caprylyl hydroxamic acid 0.05%, arginine 0.1%, and deionized water to make up the balance.
Wherein dextrin palmitate and dextrin myristate are purchased from RHEOPARL; polyglycerols were purchased from engin; tert-butylhydroquinone was purchased from Jiangsu gold Biotech limited; HDI/Trimethylolhexyllactone crosspolymer was purchased from Luborun corporation.
The vegetable oil is sweet orange grease and shea butter with the mass ratio of 1.
Peony (Paeoniascuuffructiosa) seed oil was purchased from Shanxi Henyang, china national institute of Industrial biology, inc.
Sunflower (Helianthus ANNUUS) seed oil, camellia oleifera seed oil, jojoba (Simmondsia CHINENSIS) seed oil, potentilla CHINENSIS seed oil, hibiscus deltoidea (Haematococcus PLUVIALIS) extract, mirabilis JALAPA (Mirabilis JALAPA) extract, hibiscus SYRIACUS (Hibiscus SYRIACUS) bark extract, and Rosa deserticola (Adenium OBESUM) leaf cell extract are all available from Feimao trade Co., ltd.
Prinsepia utilis Royle oil was purchased from Yunnalu Biotech limited; tocopheryl acetate was purchased from basf.
The humectant is methyl propylene glycol and glycerol with the mass ratio of 5.
In a second aspect, the present invention provides a method for preparing a cream-oil essence composition, comprising the following steps:
(1) Adding the phase A component into a stirring container, heating to 83 ℃, stirring and preserving heat until the phase A component is completely dissolved;
(2) Cooling to 70 ℃, adding the phase B component, mixing and stirring uniformly, and keeping the temperature at 70 ℃ to obtain a material I;
(3) Dispersing carbomer 940 in the phase C uniformly by using 60% of humectant, adding 50% of deionized water, mixing, heating to 80 ℃, stirring, keeping the temperature until the carbomer 940 is completely dispersed uniformly, and then cooling to 70 ℃ to obtain a material II;
(4) Adding the material I into the material II under the stirring condition until the material I is uniformly dispersed to obtain a material III;
(5) Uniformly mixing and dissolving 20% of deionized water and arginine, adding the material III, and uniformly stirring to obtain a material IV;
(6) Heating and dissolving the p-hydroxyacetophenone, the caprylyl hydroximic acid, the rest humectant and the rest deionized water, cooling to below 45 ℃, adding the material IV, and stirring uniformly.
The change of moisture content of stratum corneum after the cream prepared by the embodiment is used is shown in figure 1, the change of skin hemoglobin level is shown in figure 2, and the change of skin glossiness is shown in figure 3.
Example 2
The first aspect of the present invention provides a cream-oil essence composition, and the second aspect of the present invention provides a preparation method of the cream-oil essence composition, which is the same as that of example 1, except that the raw materials and the preparation method are as follows: 1.4% of dextrin palmitate, 2.1% of dextrin myristate, 0.7% of polyglycerol ester, 2.9% of vegetable oil and fat, 0.035% of tert-butylhydroquinone and 0.1% of HDI/trihydroxymethyl hexyl lactone cross-linked polymer.
Example 3
The first aspect of the present invention provides a cream-oil essence composition, and the second aspect of the present invention provides a preparation method of the cream-oil essence composition, which is the same as that of example 1, except that the phase B: 0.25% of peony (Paeoniascuufruticosa) seed oil, 0.5% of sunflower (Helianthus ANNUUS) seed oil, 0.25% of camellia oleifera seed oil, 0.25% of prinsepia utilis royle oil, 0.5% of jojoba (Simmondsiachinensis) seed oil, 0.25% of Potentilla alba seed oil, 1% of Haematococcus PLUVIALIS (Haematococcus PLUVIALIS) extract, 0.5% of Mirabilis JALAPA (Mirabilis japa) extract, 0.5% of Hibiscus SYRIACUS (Hibiscus SYRIACUS) bark extract, 0.5% of Rosa deserticola (Adenium) leaf cell extract, and 0.05% of tocopherol acetate.
Example 4
The first aspect of the present invention provides a cream-oil essence composition, and the second aspect of the present invention provides a preparation method of the cream-oil essence composition, which is the same as that of example 1, except that the raw materials and the preparation method are as follows: 3% of dextrin palmitate, 4.5% of dextrin myristate, 1.5% of polyglycerol ester, 5% of vegetable fat, 0.05% of tert-butylhydroquinone and 1% of HDI/trihydroxymethyl hexyl lactone cross-linked polymer;
phase B: 0.8% of peony (Paeonia SUFFRUTICOSA) seed oil, 1.5% of sunflower (Helianthus ANNUUS) seed oil, 0.8% of camellia oleifera seed oil, 0.8% of prinsepia utilis royle oil, 1.5% of jojoba (Simmondsia CHINENSIS) seed oil, 0.8% of chinaroot greens seed oil, 1% of HAEMATOCOCCUS PLUVIALIS (Haematococcus PLUVIALIS) extract, 0.5% of Mirabilis JALAPA (Mirabilis japa) extract, 0.5% of Hibiscus SYRIACUS (Hibiscus SYRIACUS) bark extract, 0.5% of Rosa deserticola (Adenium OBESUM) leaf cell extract, and 0.05% of tocopherol acetate.
Performance testing
1. Stability of cream essence.
The cream essence prepared in the examples was subjected to stability tests of 24 hours, 48 hours, 7 days and 30 days at-18 ℃, 40 ℃ and 55 ℃, respectively, and the dispersion change, particle size change and odor change of the cream essence were observed, and the data are shown in table 1.
TABLE 1
2. The stability of haematococcus pluvialis extracts with equal concentration in different systems is tested.
2.1 stability comparison of Haematococcus pluvialis extract in coagulated fat system and common fat system
Adding 8g of Haematococcus pluvialis extract based on phase A in example 1 to obtain mixed gel fat system; the phase a ingredients from example 1 were replaced with the same amount of caprylic/capric triglyceride, and 8g of haematococcus pluvialis extract was added to make a common oil system. Then, placing the two under natural illumination conditions, illuminating for 10 days at high temperature, and observing color change;
TABLE 2
High temperature of 55 DEG C | Natural illumination of light | |
Grease gelling system | No obvious color fading | Color fading occurred |
Common oil and fat system | Color fading occurred | Apparent color fading |
Adding 10% of Solubilisant LRI (purchased from Senecio) into four groups of samples with high temperature and natural light for 10 days, respectively, and adding water to 100% to obtain sample solution containing 1% of Haematococcus pluvialis extract for DPPH free radical scavenging test;
sucking 2mL of the mixed solution, placing the mixed solution into a test tube with a plug containing 4mL of water, shaking to dissolve the mixed solution, adding 2mL of 0.12mg/mL DPPH ethanol solution, standing the mixed solution in a dark place at normal temperature for 2 hours, taking the mixed solution out, measuring the light absorption value at the wavelength of 517nm, and using 95% ethanol as a blank. And (4) calculating the DPPH free radical clearance rate of the grease.
Clearance SR% = (1- (A1-A2)/A) × 100%
Wherein A1 is the absorbance of a mixed solution of the sample and the DPPH solution.
A2 is the absorbance of the mixture of the sample and 95% ethanol.
A is the absorbance of a mixture of DPPH and 95% ethanol.
TABLE 3
2.2 the haematococcus pluvialis extract with equal concentration is compared with the stability of the condensed fat oil globule essence, the common essence and the common emulsion.
Wherein the cream globule essence was prepared according to example 1, and a 1% cream globule essence of haematococcus pluvialis extract was prepared.
The common essence is prepared from the following raw materials in percentage by weight: the balance of water, 0.8 percent of carbomer 940, 0.8 percent of arginine, 0.3 percent of p-hydroxyacetophenone, 0.05 percent of caprylyl hydroximic acid, 5 percent of butanediol, 0.2 percent of hexanediol and 1 percent of haematococcus pluvialis extract.
The common emulsion is prepared from the following raw materials in percentage by weight: the balance of water, carbomer 940 0.1%, arginine 0.1%, p-hydroxyacetophenone 0.3%, caprylyl hydroximic acid 0.05%, butylene glycol 5%, hexylene glycol 0.2%, polyglyceryl-3-methylglucdistearate 3%, cetostearyl alcohol 0.6%, polydimethylsiloxane 10%, mineral oil 8%, 1% haematococcus pluvialis extract.
Then, the three are placed under natural illumination for 10 days at high temperature, and color change is observed.
10 days of test observation | High temperature of 55 DEG C | Natural illumination of light |
1%Cream essence | No obvious color fading | Little discoloration appeared |
1% of common essence | Apparent color fading | Complete fading of red |
1% Normal emulsion | Apparent color fading | Complete fading of red |
3. And (5) testing the moisturizing effect.
And (4) carrying out a moisturizing test by referring to QBT 4256-2011 cosmetic moisturizing efficacy evaluation guidelines. 24 volunteers were recruited, and two test areas having the same area were divided on the inner side of the arm of the volunteer to perform a comparative test of moisturizing the cream essence prepared in example 1 for a period of 3 hours. The test environment temperature is 21 +/-1 ℃ and the humidity is 50 +/-10%. The moisture content of the stratum corneum was measured using a moisturmeter SC (MSC 1275) skin stratum corneum hydration meter. The results are shown in table 4.
TABLE 4
0h | 1h | 3h | |
Example 1 | 24.2 | 43.7 | 39.5 |
Control group | 25.8 | 27.8 | 26.5 |
4. Testing of repair efficacy
5 volunteers were recruited and subjected to a comparative test for facial repair efficacy of the cream globule essence prepared in example 1 for a period of 14 days, with a test environment temperature of 21 + -1 deg.C and a humidity of 50 + -10%. The skin moisture loss rate through the skin (TEWL) was measured on the face using a VapoMeter (SWL 5372) moisture loss through the skin measuring instrument. The skin hemoglobin concentration Level was tested using an ANTERA 3D multifunctional 3D skin imaging analyzer (Haemoglobin Level). The results of the test mean of 5 volunteers are shown in table 5.
TABLE 5
The results show that before using the sample compared to after 14 days using the sample: the percutaneous water loss rate (TEWL) is reduced by 19.2 percent, which shows that the water-locking capacity of the skin is improved, and the barrier function of the skin is improved; the skin hemoglobin concentration Level (Haemoglobin Level) is reduced by 20.3 percent, which indicates that the skin barrier is repaired and the skin barrier function is improved.
5. Skin gloss test
5 volunteers were recruited and subjected to a comparative test for facial repair efficacy of the cream pomade essence prepared in example 1 for a period of 30min, with a test environment temperature of 21 + -1 deg.C and a humidity of 50 + -10%. Facial skin gloss was tested using the skinniness meter, skingloss meter (SGM 2015). The results show that before use of the sample compared to after 30min of use of the sample: the skin glossiness is improved by 21.8 percent, which shows that the skin glossiness can be improved.
Claims (10)
1. The cream oil essence composition is characterized by being prepared from the following raw materials:
phase A: dextrin fatty acid ester, polyglycerol ester, vegetable oil, antioxidant I and skin conditioner I;
phase B: a nourishing component, an antibacterial component, a plant extract, a skin conditioner II;
and C phase: thickening agent, antioxidant II, humectant, preservative, pH regulator and deionized water;
the sum of the mass percentages of the phase A, the phase B and the phase C is 100 percent.
2. The cream oil essence composition according to claim 1, wherein the mass ratio of the phase A to the phase B is (1-6): (1-3).
3. The curdled oil globule concentrate composition of claim 1, wherein the dextrin fatty acid ester in the a phase is selected from at least one of dextrin palmitate, dextrin myristate, dextrin stearate, dextrin laurate, dextrin isostearate, and dextrin isopalmitate.
4. The cream oil bead essence composition according to claim 1, wherein the raw materials in the phase A comprise, by mass, 0.1-20% of dextrin fatty acid ester, 0.1-20% of polyglycerol ester, 0.1-20% of vegetable oil, 0.01-1% of antioxidant I and 0.1-10% of skin conditioner I.
5. The cream oil bead essence composition according to claim 1, wherein the plant extract in phase B is at least one selected from the group consisting of Haematococcus pluvialis extract, mirabilis jalapa extract, hibiscus syriacus bark extract, rosa deserticola leaf cell extract, vitis amurensis extract, camellia japonica extract, and Aesculus hippocastanum seed extract.
6. The cream curds oil essence composition according to claim 1, wherein the mass ratio of the nourishing component, the antibacterial component and the skin conditioner II in the B phase is (1-3): (1-3): 1.
7. the cream composition according to any one of claims 5 to 6, further comprising a vitamin derivative in the B phase.
8. The cream oil bead essence composition according to claim 7, wherein the raw materials in the B phase comprise, by mass, 0.1-20% of a nourishing component, 0.1-20% of an antibacterial component, 0.01-20% of a plant extract, 0.1-10% of a skin conditioner II, and 0.01-0.5% of a vitamin derivative.
9. The cream oil bead essence composition according to claim 1, wherein the phase C comprises, by mass, 0.02-1% of a thickener, 0.01-5% of an antioxidant II, 1-15% of a humectant, 0.01-0.5% of a preservative, 0.01-2% of a pH regulator, and deionized water to make up the balance.
10. A method for preparing the cream cone essence composition according to any one of claims 1 to 9, comprising the steps of:
(1) Adding the phase A component into a stirring container, heating to 70-99 ℃, stirring and preserving heat until the phase A component is completely dissolved;
(2) Cooling to 50-90 ℃, adding the phase B component, mixing and stirring uniformly, and keeping the temperature at 50-90 ℃ to obtain a material I;
(3) Dispersing the thickener in the phase C uniformly by using 20-70% of humectant, adding 20-50% of deionized water, mixing and heating to 75-85 ℃, stirring and preserving heat until the thickener is completely dispersed uniformly, and then cooling to 50-90 ℃ to obtain a material II;
(4) Adding the first material into the second material under the stirring condition until the first material is uniformly dispersed to obtain a third material;
(5) Mixing and dissolving 10-30% of deionized water and a pH regulator uniformly, adding a material III, and stirring uniformly to obtain a material IV;
(6) Heating and dissolving the antioxidant II, the preservative, the rest of the humectant and the rest of the deionized water, cooling to below 45 ℃, adding the material IV, and uniformly stirring to obtain the composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210202527.7A CN115813844B (en) | 2022-03-03 | 2022-03-03 | Grease-condensed oil bead essence composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210202527.7A CN115813844B (en) | 2022-03-03 | 2022-03-03 | Grease-condensed oil bead essence composition and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115813844A true CN115813844A (en) | 2023-03-21 |
CN115813844B CN115813844B (en) | 2024-09-06 |
Family
ID=85522460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210202527.7A Active CN115813844B (en) | 2022-03-03 | 2022-03-03 | Grease-condensed oil bead essence composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115813844B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117064816A (en) * | 2023-09-28 | 2023-11-17 | 上海林清轩生物科技有限公司 | Camellia flower suspended oil with repairing and anti-aging effects |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008012457A1 (en) * | 2007-06-19 | 2008-12-24 | Cognis Ip Management Gmbh | Hydrocarbon mixture, useful e.g. in decorative cosmetics, preferably lipsticks, lip gloss, eye shade, mascara, eye pencil, nail polish and make-up formulations and eye shade, comprises linear hydrocarbons |
CN106236691A (en) * | 2016-09-07 | 2016-12-21 | 高宝化妆品(中国)有限公司 | A kind of antioxidation moisturizing elite dew and preparation method thereof |
CN109071727A (en) * | 2015-12-23 | 2018-12-21 | 路博润先进材料公司 | Alkali swellability emulsion polymer |
CN109106681A (en) * | 2018-09-28 | 2019-01-01 | 广东芭薇生物科技股份有限公司 | Micro- solidifying pearl cleawhite over-night essences of one kind and preparation method thereof |
CN110636827A (en) * | 2017-03-17 | 2019-12-31 | 卡普苏姆公司 | Composition comprising a fatty phase and an aqueous phase in the form of solid spheres |
CN110891545A (en) * | 2017-05-31 | 2020-03-17 | 莱雅公司 | Pickering emulsion composition comprising pearls in a fatty phase |
CN111096929A (en) * | 2020-01-13 | 2020-05-05 | 佛山博诗尼澳生物科技有限公司 | Essence with repairing and moistening effects and preparation method and application thereof |
CN111374895A (en) * | 2018-12-29 | 2020-07-07 | 伽蓝(集团)股份有限公司 | Skin care composition, preparation method and application thereof, and prepared skin care product |
US20200253858A1 (en) * | 2019-02-08 | 2020-08-13 | Amorepacific Corporation | Cosmetic composition comprising citron oil bead |
KR20200097622A (en) * | 2019-02-08 | 2020-08-19 | (주)아모레퍼시픽 | Cosmetic composition comprising citron oil bead |
JP2020158400A (en) * | 2019-03-25 | 2020-10-01 | 日本精化株式会社 | O/w emulsion composition |
CN111939089A (en) * | 2019-05-17 | 2020-11-17 | 株式会社资生堂 | Oil-in-water composition |
CN112641654A (en) * | 2021-02-05 | 2021-04-13 | 东晟源研究院(广州)有限公司 | Formula and preparation method of light essential oil with micro-coagulated beads |
-
2022
- 2022-03-03 CN CN202210202527.7A patent/CN115813844B/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008012457A1 (en) * | 2007-06-19 | 2008-12-24 | Cognis Ip Management Gmbh | Hydrocarbon mixture, useful e.g. in decorative cosmetics, preferably lipsticks, lip gloss, eye shade, mascara, eye pencil, nail polish and make-up formulations and eye shade, comprises linear hydrocarbons |
CN109071727A (en) * | 2015-12-23 | 2018-12-21 | 路博润先进材料公司 | Alkali swellability emulsion polymer |
CN106236691A (en) * | 2016-09-07 | 2016-12-21 | 高宝化妆品(中国)有限公司 | A kind of antioxidation moisturizing elite dew and preparation method thereof |
CN110636827A (en) * | 2017-03-17 | 2019-12-31 | 卡普苏姆公司 | Composition comprising a fatty phase and an aqueous phase in the form of solid spheres |
CN110891545A (en) * | 2017-05-31 | 2020-03-17 | 莱雅公司 | Pickering emulsion composition comprising pearls in a fatty phase |
CN109106681A (en) * | 2018-09-28 | 2019-01-01 | 广东芭薇生物科技股份有限公司 | Micro- solidifying pearl cleawhite over-night essences of one kind and preparation method thereof |
CN111374895A (en) * | 2018-12-29 | 2020-07-07 | 伽蓝(集团)股份有限公司 | Skin care composition, preparation method and application thereof, and prepared skin care product |
KR20200097622A (en) * | 2019-02-08 | 2020-08-19 | (주)아모레퍼시픽 | Cosmetic composition comprising citron oil bead |
US20200253858A1 (en) * | 2019-02-08 | 2020-08-13 | Amorepacific Corporation | Cosmetic composition comprising citron oil bead |
JP2020158400A (en) * | 2019-03-25 | 2020-10-01 | 日本精化株式会社 | O/w emulsion composition |
CN111939089A (en) * | 2019-05-17 | 2020-11-17 | 株式会社资生堂 | Oil-in-water composition |
CN111096929A (en) * | 2020-01-13 | 2020-05-05 | 佛山博诗尼澳生物科技有限公司 | Essence with repairing and moistening effects and preparation method and application thereof |
CN112641654A (en) * | 2021-02-05 | 2021-04-13 | 东晟源研究院(广州)有限公司 | Formula and preparation method of light essential oil with micro-coagulated beads |
Non-Patent Citations (1)
Title |
---|
张和平等: "《现代乳品工业手册》", 31 August 2005, 中国轻工业出版社, pages: 976 - 977 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117064816A (en) * | 2023-09-28 | 2023-11-17 | 上海林清轩生物科技有限公司 | Camellia flower suspended oil with repairing and anti-aging effects |
Also Published As
Publication number | Publication date |
---|---|
CN115813844B (en) | 2024-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2260829B1 (en) | Use of an extract from snow algae in cosmetic or dermatological formulations | |
CN105769666B (en) | A kind of composition and the skin care item containing said composition | |
EP4062900A2 (en) | Skin care cosmetic composition | |
CN109394585B (en) | Antioxidant and moisturizing liquid crystal composition and preparation method and application thereof | |
KR101723526B1 (en) | Cosmetic composition containing the extract of Camellia japonica flower, Prunus serrulata flower, Jasminum officinale flower, Chamomilla recutita flower and Nelumbo nucifera flower | |
CN114159347B (en) | Composition with whitening and repairing effects and preparation method and application thereof | |
CN113398016A (en) | Skin soothing and repairing composition and cosmetic composition | |
CN113081906B (en) | Astaxanthin composition and preparation method and application thereof | |
CN111467271A (en) | Skin care product containing acetylated hyaluronic acid | |
KR20210009585A (en) | Cosmetic composition for moisturizing skin comprising mixed extracts of papaver rhoeas, red clover, cimicifuga racemosa and andrographis paniculata | |
CN111374895A (en) | Skin care composition, preparation method and application thereof, and prepared skin care product | |
CN112493480A (en) | Antioxidant composition and application thereof | |
CN115813844A (en) | Cream oil bead essence composition and preparation method thereof | |
KR101326556B1 (en) | Cosmetic composition for ultraviolet-proof containing the extract of sanguisorba officinalis and v. linariaefolia | |
CN107536721B (en) | Composition for external skin preparation and use thereof | |
CN115252516A (en) | Water-feeling blush and preparation method thereof | |
CN110464672A (en) | A kind of cosmetic composition with safe antioxidant effect | |
CN113398043A (en) | Composite hermetia illucens oil composition and application thereof | |
CN115737478B (en) | Application of desert algae skin care raw material in preparation of skin soothing agent | |
CN109350562B (en) | Lip balm with anti-pollution effect | |
CN110075029A (en) | A kind of painting type green plum anti-oxidant face mask and preparation method thereof | |
CN108714130A (en) | A kind of whitening Shu Min aloe gels and preparation method thereof | |
CN109172423B (en) | Essential oil composition and preparation method and application thereof | |
CN107028827A (en) | A kind of natural anti-oxidation lipstick | |
KR101945402B1 (en) | Emulsion Containing Sea Buckthorn Oil And Cosmetic Composition For Moisturizing Skin Comprising The Same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |